G proteins and phospholipase c mediate thrombin-lnduced generation of plasminogen activator inhibitor-1 from vascular smooth muscle cells

Journal of Vascular Research

Volumn 34, Issue 2, 1997, Pages 82-89

  Ren, Song ^a   Cockell, Kevin A ^a   Fenton, John W ^b   Angel, Aubie ^a   Shen, Garry X ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b WADSWORTH CENTER   (United States)

Author keywords

Cyclic AMP; G protein; Phospholipase C; Plasminogen activator inhibitor 1; Protein kinase c; Thrombin receptor; Vascular smooth muscle cells

Indexed keywords

8 BROMO CYCLIC AMP; CALPHOSTIN C; CYCLIC AMP; FLUORIDE SODIUM; FORSKOLIN; GUANINE NUCLEOTIDE BINDING PROTEIN; NEOMYCIN; PERTUSSIS TOXIN; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOLIPASE C; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN KINASE C; THROMBIN; THROMBIN RECEPTOR;

ANIMAL CELL; AORTA MEDIA; ARTICLE; BABOON; FIBRINOLYSIS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0030901083     PISSN: 10181172     EISSN: 14230135     Source Type: Journal    
DOI: 10.1159/000159205     Document Type: Article

References (45)

1. Saksela O, Rifkin DB: Cell-associated plasminogen activation: Regulation and physiological functions, Annu Rev Cell Biol 1988:4:93-126.
2. Hamstcn A, Wiman B, dc Faire U, Blombcck M: Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction, N Engl J Med 1985:313:1557-1563.
3. Francis RB Jr., Kawanishi D, Baruch T, Mahrer P, Rahimtoola S, Fcinstein DI: Impaired fibrinolysis in coronary artery disease, Am Heart,1 1988:115:776-780.
4. Sakata K, Kurata C, Taguehi T, Suzuki S, Kobayashi A, Yamazaki N, Rydzewski A, Ta-kada Y, Takada A: Clinical significance of plasminogen activator inhibitor activity in patients with exercise-induced ischemia, Am Heart J 1990;120:831-838.
5. Cortcllaro M, Cofranccsco E, Boschetti C, Mussoni L, Donati MB, Cardillo M, Garbrielli L, Lombard B, Specchia G: Increased fibrin turnover and high PAI-1 activity as predictor of ischemic events in atherosclerotic patients, A case-control study, The PLAT Group, Arter-iosclcrThromb 1993; 13:1412-1417.
6. Yorimuilsu K, Saito T, Toyozaki T, Ishide T, Ohnama N, Inagaki Y: Immunohistochemical localization of plasminogen activator inhibitor-I in human coronary atherosclerotic lesions involved in acute myocardial infarction, Heart Vessel 1993:8:160-162.
7. Amman V, Nilsson A, Stemmc S, Risbcrg B, Rvnio L: Expression of plasminogen activator inhibitor-1 mRNA in healthy, atherosclerotic and thrombotic human arteries and veins, Thromb Res 1994;76:487-499.
8. Fenton JW II, Ofosu FA, Brczniak DV, Has-souna HI: Understanding thrombin and haemostasis, Hematol Oncol Clin North Am 1993; 7:1107-1119.
9. Laug WE, Acbersold R, Jong A, Rideout W, Bergman BL, Baker J: Isolation of multiple types of plasminogen activator inhibitors from vascular smooth muscle cells, Thromb Ilae-most 1991:61:517-521.
10. Au YPT, Kenagv RD, Clowes AW: Heparin selectively inhibits the transcription of tissue-type plasminogen activator in primate arterial smooth muscle cells during mitogenesis, J Biol Chem 1991:267:3438-3444.
11. Noda-Hcinv H, Fujii S, Sobel BE: Induction of vascular smooth muscle cell expression of plasminogen activator inhibitor-1 bv thrombin, CircRes 1993;72:36-43.
12. Wojta J, Gallicchio M, Zocllncr H, Hufnagl P, Last K, Filonzi EL, Binder BR, Hamilton JA, Magrath K: Thrombin stimulates expression of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in cultured human vascular smooth muscle cells, Thromb Haemost 1993:70:469-474.
13. Cockell KA, Ren S, Sun J, Angel A, Shen GX: Effect of thrombin on release of plasminogen activator inhibitor-! from cultured primate arterial smooth muscle cells, Thromb Res 1995; 77:119-131.
14. Francis RB Jr., Neely S: Inhibition of endothelial secretion of tissue-type plasminogen activator and its rapid inhibitor by agents which increase intracellular cyclic AMP, Biochim Biophys Acta 1989; 1012:207-213.
15. Grulich-Henn J, Muller-Berghaus G: Regulation of endothelial tissue plasminogen activator and plasminogen activator inhibitor type I by diacylglycerol, phorbol ester, and thrombin, Blut 1990:61:38-44.
16. Villamediana LM, Rondeau E, He C-J, Med-calf RL, Peraldi MN, Lacave R, Sracr JD: Thrombin regulates component of the fibrinolytic system in human mcsangial cells, Kidney Int 1990:38:956-961.
17. He C-J, Peralsi MN, Rebibou JM, Mculdcrs Q, Sracr JD, Rondeau E: Thrombin signal transduction mechanisms in human glomerular epithelial cells, J Cell Physiol 1992; 150:475-483.
18. Maruyama Y, Manivama I, Soejima Y: Thrombin receptor agonist peptide decreases thrombomodulin activity in cultured human umbilical vein endothelial cells, Biochcm Biophys Res Commun 1994:199:1262-1269.
19. van Hinsbergh VW, Vermeer M, Koolwijk P, Grimbergh J, Koostra T: Gcnistcin reduces tumor necrosis factor a-induced plasminogen activator inhibitor-1 transcription but not urokinase expression in human endothelial cells, Blood 1994:84:2984-2991.
20. Fccncr EP, Northrup JM, Aiello LP, King GL,: Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells, J Clin Invest 1995:95:1353-1362.
21. Fenton JW II, Fasco MJ, Stackrow AB, Aronson DL, Young AM, Finlayson JS: Human thrombins, Production, evaluation, and properties of u-thrombin, J Biol Chem 1977.252: 3587-3598.
22. Bing DPI, Cory M, Fenton JW II: Exositc affinity labelling of human thrombins, Similar labelling on the A chain and B chain/fragments of clotting a- and nonclotting y/ß-lhrombins, J Biol Chem 1977;252:8027-8034.
23. Beecher KL, Anderson IT, Fenton JW II, Fes-toff BW: Thrombin receptor peptides induce shape change in neonatal murine astrocytes in culture, J Ncurosci Res 1994:37:108-115.
24. Shen X-Y, Hamilton TA, DiCorleto PE: Lipo-polysaccharide-induced expression of the competence gene KC in vascular endothelial cells is mediated through protein kinase C, J Cell Physiol 1989;140:44-51.
25. Chirgwin JM, Prvzbyla AE, MacDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonu-clease, Biochemistry 1979; 18:5924-5929.
26. Southern E: Detection of specific sequences among DNA region of the thrombin receptor resembling hirudin binds to thrombin and alters cnzvmatic specificity, J Mol Biol 1975:98: 503-517.
27. Wun T-C, Kretzmer KK: cDNA cloning and expression in E, co/i of a plasminogen activator (PAI) related to a PAI produced by HepG2 hepatoma cell, FEBS Lett 1987:210:11-16.
28. Fenton JW II, Olson TA, Zabinski MP, Wilner GD: Anion-binding exositc of human a-throm-bin and fibrin(ogen) recognition, Biochemistry' 1988:27:7106-7112.
29. Kawamoto S, Hidaka H: l-(5-Isoquinol incsul-fony)-2-methylpiperazine (H-7) is a selective inhibitor of protein kinase C in rabbit platelets, Biochem Biophys Res Commun 1984:125: 258-264.
30. Levin EG, Marotti KR, Santell L: Protein kinase C and the stimulation of tissue plasminogen activator release from human endothelial cells, J Biol Chem 1989:264:16030-16036.
31. Rydholm H, Bostrom S, Eriksson E, Risbcrg B: Complex intracellular signal transduction regulates tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) synthesis in cultured human umbilical vein endothelium, Scand J Clin Lab Invest I995;55:323-330.
32. Kobayashi E, Nakano H, Morimoto M, Ta-maoki T: Calphostin C (UCN-I028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C, Biochem Biophys Res Commun 1989; 159:548-553.
33. Gilman AG: G protein: Transduction of receptor-generated signals, Annu Rev Biochem 1987;56:615-649.
34. Ncvlon CB, Nickashin A, Little PJ, Tkachuk VA, Bobik A: Thrombin-induced Ca-* mobilization of vascular smooth muscle utilizes a slowly ribosylating pertussis toxin-sensitive protein: Evidence for the involvement of a G protein in inositol trisphosphate-dcpcndenl Ca-‘release, J Biol Chem 1992:267:7295-7302.
35. Xuan Y, Su YF, Chang KJ, Watkins WD: A pertussis cholera toxin sensitive G-protein may mediate vasopressin-induced inositol phosphate formation in smooth muscle cell, Biochem Biophys Res Commun 1987; 146:898-906.
36. Garcia JG: Molecular mechanism of thrombin-induced human and bovine endothelial cell and activation, J Lab Clin Med 1992; 120:513-519.
37. Sicss W, Lapctina EG: Neomycin inhibits inositol phosphate formation in human platelets stimulated by thrombin but not other agonists, FEBS Lett 1986:207:53-57.
38. Pertile P, Liscovitch M, Chalifa V, Cantley LC: Phosphatidylinositol 4.5-bisphosphate synthesis is required for activation of phospholipasc D in U937 cells, J Biol Chem 1995:270:5130-5135.
39. Tatrai A, Lee SK, Stern PH: U-73122. a phos-phohpaseC antagonist, inhibits effects of endo-thelin-1 and parathyroid hormone on signal transduction in UMR-106 osteoblastic cells, Biochim Biophys Acta 1994:1224:575-582.
40. Zacharias U, Xu Y, Hagege J, Sraer ID, Brass LF, Rondeau E: Thrombin, phorbol ester, and cAMP regulate thrombin receptor protein and mRNA expression by different pathways, J Biol Chem 1995:270:545-550.
41. Park DJ, Min HK, Rhcc SG: Inhibition of CD3-linked phospholipasc C by phorbol ester and by cAMP is associated with decreased phosphotyrosinc and increased phosphoserine contents of PLC-gamma 1. J Biol Chem 1992: 267:1496-1501.
42. Bevilaqua MP, Schlccf RR, Gimbrone MA, Loskutoff DJ: Regulation of the fibrinolytic system of cultured human endothelium by interleukin-1. J Clin Invest 1986:78:587-591.
43. Nachman RL, Hajjar KA, Silvcrson RL, Di-narello CA: Interleukin-1 induces endothelial cells synthesis of plasminogen activator inhibitor, J Exp Med 1986:163:1260-1266.
44. Stem DM, Bank I, Nawroth PP, Cassimers J, Kisicr W, Fenton JW II, Dinarcllo C, Chess L, Jaffe EA: Self regulation of procoagulant events on the endothelial surface, J Exp Med 1985; 162:1223-1225.
45. Heaton JII, Dame MK, Gelehrter TD: Thrombin induction of plasminogen activator inhibitor mRNA m human umbilical vein endothelial cells in culture, J Lab Clin Med 1992:120: 220-228.